Tablet vs Capsule: Which Works Better? Read the Release Code

For the same drug at the same strength and release type, neither a tablet nor a capsule is better, and a capsule does not work faster by default. How quickly a medicine acts depends on how the product was formulated: whether it releases at once, slowly, or only after it leaves the stomach.

Our explanation: in an immediate-release product, a capsule shell opens and a tablet disintegrates within a short time. Any real difference in speed comes from the formulation inside (particle size, solubility, coating, release design), not from the container.

Regulators test the result, not the shape. Bioequivalence means a generic delivers the same drug into the blood at the same rate and to the same extent as its brand-name reference. The rate is shown by the peak blood concentration (Cmax) and the extent by the total exposure over time (area under the curve, or AUC). A 90% confidence interval is the range in which the true ratio between the two products lies with 90% confidence. For human generics, FDA expects the 90% confidence interval of the test-to-reference ratio for Cmax and AUC to fall within 80.00% to 125.00% (FDA, Statistical Approaches to Establishing Bioequivalence).

That testing is done product by product. A 10 mg capsule from one maker and a 10 mg tablet from another have not been compared with each other unless a study did so. Treat them as different products until a prescriber or pharmacist says otherwise.

You can open, split or crush a pill only when the label or a pharmacist confirms that exact product allows it. A release code in the name means the answer is no unless the label says otherwise. The table turns this into a decision.

The letters mean: XR, ER and XL, extended-release (over many hours); SR, sustained-release; CR, controlled-release; LA, long-acting; DR and EC, delayed-release or enteric-coated, built to open in the intestine rather than the stomach. No code usually means immediate-release, which starts releasing at once.

A few capsules are labeled for opening and sprinkling on soft food. That instruction comes from the label of that exact product, and the beads inside are still swallowed whole, never crushed or chewed. Labels are revised, so a pharmacist should check the current one for your product.

Run these four tests before you open, split, crush or switch.

What to say at the counter: "I take [name on the label, strength]. I can't swallow it whole. Can this exact product be opened, split or crushed? If not, is there a liquid, chewable or dissolving form of the same drug?"

The release code matters more than the shape because modified-release products exist in both forms, and in our count of US generic listings they are more common among capsules. In October 2026, 22.5% of capsule listings and 12.8% of tablet listings named an extended- or delayed-release form.

"Modified-release" here means any product built to release its drug over hours or at a set point in the gut.

How we counted. On 9 October 2026 we queried the openFDA National Drug Code directory (data updated 8 October 2026). The query covered finished drugs under the abbreviated new drug application (ANDA) category, which is the route for US generics, counted by dosage-form term. The 29,746 tablet listings are the sum of all 13 terms beginning "TABLET", and the 7,888 capsule listings the sum of all 9 terms beginning "CAPSULE". The other 25,943 tablet listings are plain, film-coated, sugar-coated, chewable, orally disintegrating or for-suspension forms. The other 6,116 capsule listings are plain, liquid-filled, gelatin-coated or coated-pellet forms. Overall, tablets are 79.0% of the 37,634 listings and capsules 21.0%. Only terms that name the release type are counted as modified-release, so the shares are minimums. Listings are one per product entry, not distinct drugs or prescriptions. A capsule listing is about 1.8 times as likely as a tablet listing (22.5 ÷ 12.8) to be modified-release. That ratio is our reading of the count, not an FDA statement.

Two same-molecule examples show why "tablet" or "capsule" alone tells you little. In the same directory (all marketing categories, queried 9 October 2026), bupropion has 352 finished-drug listings, all tablets or kits. Of these, 265 (75%) are extended-release tablets (160 + 103 + 2), and the rest include 56 film-coated and 29 plain tablets. "Bupropion tablet" alone does not say how a product releases. Omeprazole appears as 205 delayed-release capsule listings and 144 delayed-release tablet listings (126 plus 18 orally disintegrating). In both forms the product is built to release further down the digestive tract, so the instruction follows the design and the label, not the shell.

Neither form is consistently easier to swallow, and technique helps more than the form. In a 2014 Heidelberg University study of 151 adults, 55.6% of whom reported trouble swallowing solid doses, the pop-bottle method made 59.7% (169 of 283) of the hardest-to-swallow tablets easier to swallow. The lean-forward method did so for 88.6% (31 of 35) of the hardest capsules (Schiele et al., Annals of Family Medicine).

The capsule figure rests on only 35 swallows, and each method was tested on one form, so the study does not show that capsules are easier than tablets.

• Tablets, pop-bottle method: fill a plastic water bottle, put the tablet on your tongue, seal your lips around the opening and swallow with a sucking motion.
• Capsules, lean-forward method: put the capsule on your tongue, take a sip of water without swallowing, tilt your chin toward your chest, then swallow.

If a pill is still too hard to swallow, tell your pharmacist or prescriber and ask whether the same drug comes as a liquid, a chewable or an orally disintegrating tablet. Do not crush or open it yourself until you have checked the table above.

A caplet is a tablet shaped like a capsule, a softgel is a capsule with a soft, sealed shell, and a veggie capsule has a shell made from plant-based material instead of animal gelatin. None of them changes the rule: the release code and the label decide.

A caplet is still a compressed tablet, so tablet rules apply. A softgel or a veggie capsule is a capsule, so capsule rules apply. If you avoid animal products, the shell material is the practical difference between a veggie capsule and a gelatin one, and the label lists it.

For vitamin D, the NIH Office of Dietary Supplements says it is best absorbed when taken with a meal or snack that includes some fat. Our recommendation for any supplement is to choose the form you will actually take every day and compare the amount per serving, not the shape.

A formulator chooses between a tablet and a capsule by what the active ingredient and the patient need: dose size, taste, release profile and who will swallow it. The active pharmaceutical ingredient (API) is the substance that produces the therapeutic effect. These factors are our view, drawn from formulation practice.

• Dose size. A high-dose ingredient is often easier to compress into a tablet than to fit into a capsule a patient can swallow.
• Taste and handling. A bitter, odorous or oily ingredient often suits a capsule, and a soft capsule suits a liquid or oil fill.
• Patients who cannot swallow a whole tablet. Dispersible tablets, which disintegrate in water before being taken, are designed for this, as we explain in our dispersible tablets guide.
• Release profile. Either form can carry extended or delayed release, so the target is set in development, not by the shell.

We are Aarise Pharmaceuticals, a pharmaceutical company in Haridwar, India. As a technology-driven contract development and manufacturing organization (CDMO) for oral dosage forms, we develop and manufacture finished products for generic-drug manufacturers, contract formulators and pharmaceutical distributors, including tablets and capsules. Our route runs from inquiry through feasibility review, commercial quotation, development or technical transfer (moving an existing product's process to a new site), production and quality control, packaging, and dispatch. We supply businesses, not individual patients, and we do not give personal medical advice. For your own medicine, ask your pharmacist.

If you are developing an oral product and want to settle the form early, request a feasibility review for a tablet or capsule product. We quote after the review.